Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
XORTX Announces US$1.5 Million Registered Direct Offering and Concurrent Private Placement
Oct 17, 2024•over 1 year ago
Contract Type
partnership
CalgaryBiotechnologyHealth CareTherapeuticsPharmaceuticalPharmaceutical ManufacturingDescription
XORTX Therapeutics Inc. has entered into securities purchase agreements with institutional investors for the purchase and sale of common shares and common warrants in a registered direct offering and concurrent private placement. The gross proceeds from the Offering are expected to be approximately US$1.5 million, and the net proceeds will be used for working capital and general corporate purposes.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months